| Last visit was: 06 Jun 2026, 00:24 |
It is currently 06 Jun 2026, 00:24 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2023 | 750 GMAT Classic | 1 | 7 | India |
07 Dec 2022 01:16 PM
|
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2023 | 730 GMAT Classic | 4 | 6 | Consulting | India |
07 Dec 2022 12:17 PM
|
| Full Time MBA |
Admitted
|
Round 1 | 2023 | 700 GMAT Classic | 3.9 | 0 | Philippines |
07 Dec 2022 11:50 AM
|
|
| Full Time MBA |
Admitted
|
Round 1 | 2023 | 600 GMAT Classic 159 EA |
3.4 | 3 | Consulting | Peru |
07 Dec 2022 11:38 AM
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2023 | 332 GRE | 3.2 | 7 | China |
07 Dec 2022 11:22 AM
|
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2023 | 680 GMAT Classic 740 GMAT Classic |
4 | 7 | India |
07 Dec 2022 10:57 AM
|
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2023 | 331 GRE | 3.9 | 6 | India |
07 Dec 2022 10:52 AM
|
|
| Full Time MBA |
Admitted
|
Round 1 | 2023 | 680 GMAT Classic 760 GMAT Classic |
3.6 | 5 | Consulting | India |
07 Dec 2022 10:00 AM
|
| Full Time MBA |
Admitted
|
Round 1 | 2023 | Consulting | Nigeria |
07 Dec 2022 09:58 AM
|
|||
| Full Time MBA |
Admitted
|
Round 1 | 2023 | 3.9 | 5 | Consulting | Bangladesh |
07 Dec 2022 09:55 AM
|
|
| Full Time MBA |
Admitted
|
Round 1 | 2023 | 338 GRE | 4 | Nigeria |
07 Dec 2022 04:47 AM
|
||
| Full Time MBA |
Interviewed
|
Round 1 | 2023 | 4 | 0 | Peru |
07 Dec 2022 01:36 AM
|
||
| Full Time MBA |
Denied with Interview
|
Early Action | 2023 | 680 GMAT Classic | 2.3 | 2 | Consulting | United States |
06 Dec 2022 10:18 PM
|
| Full Time MBA |
Withdrawn Application
|
Early Action | 2023 | 750 GMAT Classic | 3.7 | 5 | Consulting | India |
30 Nov 2022 10:49 AM
|
| Full Time MBA |
Interviewed
|
Round 1 | 2023 | 770 GMAT Classic | 3.3 | 5 | United States |
21 Nov 2022 09:44 AM
|
|
| Full Time MBA |
Admitted, ($$$$)
|
Early Action | 2023 | 4 | 4 | Pharmaceuticals and Biotech | United States |
17 Nov 2022 10:38 AM
|
|
| Full Time MBA |
Denied with Interview
|
Early Action | 2023 | 3.5 | 4 | Indonesia |
21 Oct 2022 03:32 AM
|
||
| Full Time MBA |
Waitlisted with Interview
|
Early Action | 2023 | 316 GRE | 3.8 | 1 | India |
21 Oct 2022 12:07 AM
|
|
| Full Time MBA |
Waitlisted with Interview
|
Early Action | 2023 | 750 GMAT Classic | 4 | 5 | Computer Software | India |
20 Oct 2022 01:04 PM
|
| Full Time MBA |
Admitted
|
Early Action | 2023 | 327 GRE | 5 | India |
20 Oct 2022 04:30 AM
|